中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
16期
2406-2407
,共2页
蔡建华%张近波%吴仙丹%许国斌
蔡建華%張近波%吳仙丹%許國斌
채건화%장근파%오선단%허국빈
胰腺炎%治疗,临床研究性%肾替代疗法
胰腺炎%治療,臨床研究性%腎替代療法
이선염%치료,림상연구성%신체대요법
Pancreatitis%Therapies,investigational%Renal replacement therapy
目的:探讨连续性肾替代治疗( CRRT)时机对重症急性胰腺炎( SAP)患者疗效的影响。方法回顾性分析38例重症急性胰腺炎患者的临床资料,按开始CRRT时机分为两组,早期组(21例)为重症急性胰腺炎发病后48 h内行连续性肾替代治疗,晚期组(17例)为48 h以后行连续性肾替代治疗,比较两组APACHEⅡ评分、ICU住院时间、28 d病死率。结果与早期组比较,晚期组第1、2天时APACHEⅡ评分均明显升高( t=2.231、2.304,均P<0.05);与早期组比较,晚期组入院时、CRRT开始时APACHEⅡ评分差异均无统计学意义(均P>0.05);与早期组比较,晚期组ICU住院时间、28 d病死率均明显升高( t=2.156,χ2=4.293,均P<0.05);两组入院时年龄、性别、APACHE Ⅱ评分等差异均无统计学意义(均P>0.05)。结论早期行CRRT治疗,可以降低SAP患者病死率,减少住院时间。
目的:探討連續性腎替代治療( CRRT)時機對重癥急性胰腺炎( SAP)患者療效的影響。方法迴顧性分析38例重癥急性胰腺炎患者的臨床資料,按開始CRRT時機分為兩組,早期組(21例)為重癥急性胰腺炎髮病後48 h內行連續性腎替代治療,晚期組(17例)為48 h以後行連續性腎替代治療,比較兩組APACHEⅡ評分、ICU住院時間、28 d病死率。結果與早期組比較,晚期組第1、2天時APACHEⅡ評分均明顯升高( t=2.231、2.304,均P<0.05);與早期組比較,晚期組入院時、CRRT開始時APACHEⅡ評分差異均無統計學意義(均P>0.05);與早期組比較,晚期組ICU住院時間、28 d病死率均明顯升高( t=2.156,χ2=4.293,均P<0.05);兩組入院時年齡、性彆、APACHE Ⅱ評分等差異均無統計學意義(均P>0.05)。結論早期行CRRT治療,可以降低SAP患者病死率,減少住院時間。
목적:탐토련속성신체대치료( CRRT)시궤대중증급성이선염( SAP)환자료효적영향。방법회고성분석38례중증급성이선염환자적림상자료,안개시CRRT시궤분위량조,조기조(21례)위중증급성이선염발병후48 h내행련속성신체대치료,만기조(17례)위48 h이후행련속성신체대치료,비교량조APACHEⅡ평분、ICU주원시간、28 d병사솔。결과여조기조비교,만기조제1、2천시APACHEⅡ평분균명현승고( t=2.231、2.304,균P<0.05);여조기조비교,만기조입원시、CRRT개시시APACHEⅡ평분차이균무통계학의의(균P>0.05);여조기조비교,만기조ICU주원시간、28 d병사솔균명현승고( t=2.156,χ2=4.293,균P<0.05);량조입원시년령、성별、APACHE Ⅱ평분등차이균무통계학의의(균P>0.05)。결론조기행CRRT치료,가이강저SAP환자병사솔,감소주원시간。
Objective To explore the effects of continuous renal replacement thempy ( CRRT) on efficacy in severe acute pancreatitis ( SAP) patients based on different time .Methods A total of 38 SAP patients were divided into two groups randomly:early group(CRRT within 48h) for 21 patients and late group(CRRT after 48h)for 17 pa-tients.the APACHE II score,the length of stay ICU and the mortality of 28d were compared between the two groups . Results The APACHE Ⅱscore was significantly higher in late group than that in early group in day 1 and 2 ( t=2.231,2.304,both P<0.05);there is no significant differences between late group than that early group in APACHEⅡscore before treatment(P>0.05);the hospitalizing days and mortality were significantly higher in late group than that in early group(t=2.156,χ2 =4.293,both P<0.05);there was no significant differences between late group and early group in gender,age,APACHEⅡscore(all P>0.05).Conclusion Early CRRT can decrease both the hospi-talizing days and mortality in SAP patients .CRRT may provide more clinical benefits in the early phase (within 48h) of SAP.